Be Clinical

The August INR 21 crore seed extension is a financing event, not proof of efficacy or demand. Capital allocated to evidence and production can improve control while adding fixed costs and execution pressure. The relevant next evidence is product-specific study reporting, repeat cohorts and use of manufacturing capacity; valuation, revenue and profitability remain undisclosed.